Zhenfeng Shi

Title: Zhenfeng Shi: Innovator in Pharmaceutical Research

Introduction

Zhenfeng Shi is a prominent inventor based in Xi'an, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of innovative compounds targeting viral proteases. With a total of 3 patents, his work is paving the way for new therapeutic approaches.

Latest Patents

Zhenfeng Shi's latest patents include groundbreaking research on Protacs targeting the coronavirus 3CL protease. One of his patents discloses a compound of formula I or formula II, which includes a pharmaceutically acceptable salt or a tautomer thereof. The patent details that the linker is or and n is between 1-6. Another significant patent focuses on Protacs based on VHL ligand targeting the same protease, again presenting a compound of formula I or formula II with similar specifications regarding n.

Career Highlights

Throughout his career, Zhenfeng Shi has worked with notable organizations such as Shaanxi Panlong Pharmaceutical Co., Ltd. and Shaanxi University of Science and Technology. His experience in these institutions has allowed him to collaborate on various innovative projects that contribute to the advancement of pharmaceutical sciences.

Collaborations

Zhenfeng Shi has collaborated with several professionals in his field, including Chengyuan Liang and Lei Tian. These partnerships have enhanced his research capabilities and have led to the development of impactful inventions.

Conclusion

Zhenfeng Shi's contributions to pharmaceutical research and his innovative patents demonstrate his commitment to advancing medical science. His work continues to inspire future developments in the field.